•Over 35 years of experience in health care •Chief Executive Officer of a 13-site state operation for a private ambulatory health care agency •Leader in a variety of not-for-profit and investor-owned health care delivery organizations •Over 15 years of experience at The Joint Commission and 18 years at Joint Commission International Thomas Kozlowski joined Joint Commission Resources in 2001 and subsequently consulted with both domestic and international health care organizations in the areas of accreditation readiness and standards compliance. Dr. Kozlowski's consulting expertise in hospital, ambulatory care, behavioral health care, and long term care settings includes operational assessment; patient safety assessment; environment of care; executive leadership and governing bodies; performance improvement; implementation strategies for rapid response teams; electronic health record assessment; and incorporating tracer methodology and the periodic performance review as management tools. Dr. Kozlowski has consulted internationally in Asia Pacific Region, Europe, the Middle East and the Americas. EXPERIENCE WITH HEALTH CARE FACILITIES •Associate Director of Operations for the Accreditation Division, The Joint Commission •Associate Director for the Department of Standards, The Joint Commission •Administrator in freestanding hospitals, inpatient and outpatient mental health and chemical dependency programs, residential programs, and foster care organizations •Chief Executive Officer for ambulatory health care statewide system •Interim Director of Accreditation/Regulation and Quality for an academic teaching acute care hospital and multi-site ambulatory system •Corporate Director of Quality Improvement and Research for a multi-state health maintenance organization

Healthcare Administration

Dr. Sharma serves as Consultant OncoPathologist at SRL Diagnostics. He has in the past served as Consultant Onco-pathologist, molecular pathologist and Head of Quality assurance at CORE Diagnostics, Gurgaon. He has done MBBS from Manipal with distinction in 5 subjects, an aggregate percentage of 73% with highest marks in Pathology. He has trained in oncopathology at HCG Cancer Hospital, Bangalore from where he completed his primary DNB. He was previously working as Block Chief Medical Officer with Govt. of Rajasthan. He is an expert orator and has delivered talks as Guest speaker at numerous forums nationally like Indian Cancer Congress, YROC, Oncocon, BCFICON etc and internationally at numerous conferences like PathSoc (UK), Nigerian Medical Association, Bangladesh Association of haematologists etc. He has had the distinction of being the faculty, mentor for the First national Hands on IHC workshop of the country, held at JNMC, Belgavi at the 36th National Pathology CME. He recently presented his study on 156 cases of Diffuse large B cell lymphomas with double and triple hit at International Lymphoma and Myeloma congress, New York. He has numerous publications in national and international journals like South Africal Journal of Gynecological oncology, RCPATH and Archives of Pathology including the first reported case of cellular ovarian fibroma from India and presentations at conferences like College of American Pathologists (CAP, Chicago), International Society of Paediatric Oncology (SIOP) (Kyoto, Japan) and Myanmar Society of Hematology. He has had the distinction of reporting nearly 500 cases of lymphomas annually. He is a member of numerous organisations like Indian Association of Pathologists and The Cytometry Society of India. His main areas of work include Oncopathology, IHC, Lymphomas, Flowcytometry and Molecular assays in cancer.

Oncopathologist

Professor Vinay Sharma is Head, Department of Radiation Oncology at Charlotte Maxeke Johannesburg Academic Hospital, University of Witwatersrand. He has published over 150 papers in in national and international peer reviewed journals as well as book chapters. He has delivered over 100 lectures His main research interest is in breast cancers as well as gynecological malignancies.

Radiation oncology

Dr. Ko obtained his PhD degree in Pharmacology at the University of Hong Kong Medical School after completion of his undergraduate training at the University of Toronto, Canada with double specialists in Toxicology and Nutritional Sciences. He has been actively involved in many research projects, published over 100 papers in reputed journals and serving as an editorial board member of various journals including those of the Nature Publishing Group. He is currently member of the American Association for Cancer Research (AACR), European Association for Cancer Research (EACR) and International Union of Basic and Clinical Pharmacology (IUPHAR).

Clinical Pharmacology

Dr. Daniel Gandia is a Clinical Oncologist that has been and is involved in Cancer Medicine for many years. He is involved in the guidance of Clinical Oncology Trials in an important worldwide American CRO. He has published several papers in important Journals and he also teaches Cellular and Molecular Biology at the School of Medicine in Buenos Aires. Mathematical Oncology has become in last years a quiz for him. Email: [email protected]

Clinical Oncology

Prissadee Thanaphongdecha has done Doctoral of philosophy in Pathobiology and Bachelor degree in Medical science. He is currently working in Faculty of medicine, Khonkaen university, Thailand

Pathobiology

Dr. Paulus S. Wang was a professor of the Department of Physiology, National Yang-Ming University (NYMU). Now he is a Chair-Professor and also the Director in the Medical Center of Aging Research, China Medical University Hospital (CMUH). During his academic life in NYMU and CMUH. Dr. Wang creates the concept that the lactate caused by exercise stimulates the productions of progesterone in females and testosterone in males and that both digitalis and bufalin inhibit the proliferation of different human prostate cancer cells. He established the Master and Ph. D. programs for the Institute of Physiology in NYMU. He is the Founder of both the Society of Adaptive Science in Taiwan (SAST) and the Taiwan Society of Endocrinology and Metabolism (TSEM).

Physiology

Salam Azad is a freelance Writer and President of Soheli Mirza Cancer Foundation. Azad had raised the issue of Islamist fundamentalism. Madrasa (Islamic School) education and the practice of issuing fatwa. A fearless writer, continues to crusade against injustice committed by Bangladesh society and government, particularly the failure to protect the rights of the minorities.

Cancer studies

Baljeet Singh Talwar is a graduate from Moscow Power Engineering Institute (Technical University) with a passion of Microwave Technology and has a vast experience in International Business in healthcare(Pharmaceutical & Information Technology).He has the experience of handling scientific and technical development, management of research, interaction with medical consultants of the project. Organization of R & D, production of medical equipment, international scientific cooperation & publications.

Advanced Preventive Medicine.

MS. SUCHI is an experienced International Pre School Principal/Manager who picked up Laughter exercises from many coaches around the world. She then designed ‘Laughter Therapy' which is being used in many places such as hospitals and Senior Activity Centres. She provides individual and group therapy in educational and home settings.

Neurology/Psychiatry /Public Health

Dr. Yonghua Yang is currently a professor in the Department of Biochemistry & Pharmacology of Fudan University with a focus on breast cancer. Dr. Yang obtained his B.S. in Organic Chemistry from Jilin University in 1987. He continued his postgraduate studies in Shanghai Institute of Materia Medica, CAS and obtained his Ph.D. in Pharmacy and Pharmacology in 1993 and 1998, respectively. He is working with trainees in his laboratory on the characterization and development of novel molecules significant in breast tumorigenesis. He published a series of first author and senior author publications in recognized peer-reviewed journals, including Nature Cell Biology, EMBO J, PNAS, Cancer Research, and Oncogene etc.

My current research focuses on exploring the roles and molecular mechanisms of cancer-related proteins in tumorigenesis and metastasis, as well as molecular targets for cancer therapeutics and anticancer drug development via molecular biology, cell biology, genetics and other approaches.

Dr. Polly Chen is an Assistant Professor in the Department of Anatomy and a principle investigator at the Cancer Science Institute of Singapore, National University of Singapore where she directs a research lab studying human cancers, particularly liver cancer. Her group currently focuses on the identification of key RNA editing events and translating these findings into diagnoses and even treatment. In addition, she has begun collaborating with local and international researchers to study the roles of RNA editing enzyme ADARs and their substrates in different types of human cancers, such as esophageal squamous cell carcinoma (ESCC), Gastric cancer and acute myeloid leukemia (AML).

Hepatocellular carcinoma (HCC), Transcriptome instability of human cancers, Regulation of tumorigenesis by transcriptome instability.

Dr. Lingzhi Wang is a Senior Research Scientist at the Cancer Science Institute of Singapore and an Assistant Professor in the Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore (NUS). Dr. Wang obtained his M.Med. in Medicinal Chemistry from Chongqing Medical University in 1993. He continued his postgraduate studies in NUS and obtained his M.Sc. in Pharmacy and Ph.D. in Pharmacology in 2003 and 2008, respectively. Dr. Wang received the Medical Research Scientist Award from the National Medical Research Council (NMRC Singapore) in 2005, and the PhD Graduate Research Excellence Award from the American Association of Pharmaceutical Scientists (AAPS) at its Annual Meeting in 2008 (USA). To date, he is the author of over 70 research papers, including articles in Cell, Journal of Clinical Oncology, Clinical Cancer Research, Trends in Pharmacology, and Trends in Biotechnology etc.

His research interests are in the development of novel combination therapies against a variety of cancers, identification of anticancer agents from natural products, preclinical cancer pharmacology, and discovery of bio-fluid exosomal biomarkers for cancer diagnosis.

Carrie Yuen is a Hong Kong native and a board certified internist and pediatrician. She has many years of clinical practice experience and has a particular interest in immunology and translational research on cellular therapy. Her passion is to improve the understanding of disease process, GVHD, and to investigate potential application of cellular therapy in the field of transplant with a goal of improving overall survival and minimize toxicity of current transplant regimens. She joined the faculty at the Stephenson Cancer Center in 2012. She is an assistant professor in the Section of Hematology/Oncology and works primarily with the Blood and Marrow Transplant Program.

Hematologic malignancies, Benign hematology, Bone marrow transplant, Pediatric long-term cancer survivor.

Caroline Lee graduated with PhD from Baylor College of Medicine and did her post-doctoral training at the National Cancer Institute, National Institutes of Health. She currently also holds joint appointment as Principal Investigator at the National Cancer Centre as well as an Associate Professor at the Cancer and Stem Cell Biology Program at Duke-NUS Graduate Medical School. She has ~100 peer reviewed publications and research focuses on the functional genomics of hepatocellular carcinoma (HCC) and pharmacogenetics.

Pharmacogenetics, Tumorigenesis, Cancer Functional Genomics, Carcinogenesis, Identify Biomarkers for hepatocellular carcinoma (HCC).

Peter obtained his B.Sc (Hons) in Microbiology from University of Malaya in 1992 and a Doctor of Philosophy (D.Phil) in Biochemistry/Molecular Biology from Exeter College, University of Oxford in 1998. He was a Research Scientist, and Head of Microarray Group with A-Star Bioprocessing Technology Institute in Singapore (2001 to 2010) prior to joining the Faculty of Engineering, Computing and Science, Swinburne University of Technology Sarawak Campus. His areas of expertise are molecular and cellular biology, system biology and genomics with specialization in high throughput gene expression profiling using DNA microarray and Next-Gen sequencing technologies. He has a H-index of 15 and have published journal papers and book chapters, in the subject area of genomics and gene expression analysis.

Identifying biomarkers from genomics and proteomics data, Biomarkers discovery for cancer and immune disorders, Exploring miRNAs as potential therapeutics targets.